Talis Biomedical Corporation (TLIS)
NASDAQ: TLIS · IEX Real-Time Price · USD
8.74
+0.07 (0.81%)
At close: Jul 19, 2024, 12:00 AM
8.57
-0.17 (-1.95%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Talis Biomedical Employees
Talis Biomedical had 99 employees as of December 31, 2023. The number of employees decreased by 3 or -2.94% compared to the previous year.
Employees
99
Change (1Y)
-3
Growth (1Y)
-2.94%
Revenue / Employee
$9,990
Profits / Employee
-$577,889
Market Cap
15.93M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 99 | -3 | -2.94% |
Dec 31, 2022 | 102 | -160 | -61.07% |
Dec 31, 2021 | 262 | 126 | 92.65% |
Dec 31, 2020 | 136 | - | - |
Related Stocks
Company Name | Employees |
---|---|
China Jo-Jo Drugstores | 938 |
Centogene | 384 |
BIMI International Medical | 296 |
Microbot Medical | 22 |
Chemomab Therapeutics | 20 |
Edesa Biotech | 16 |
Galecto | 13 |
Immuron | 6 |
TLIS News
- 8 months ago - Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve Cash - GlobeNewsWire
- 1 year ago - Talis Biomedical Announces Second Quarter 2023 Financial Results and Business Update - GlobeNewsWire
- 1 year ago - Talis Biomedical to Report Second Quarter 2023 Financial Results and Provide a Business Update on August 10, 2023 - GlobeNewsWire
- 1 year ago - Talis Biomedical Announces Andrew Lukowiak, Ph.D., as President and Chief Scientific Officer (CSO) - GlobeNewsWire
- 1 year ago - Talis Biomedical Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewsWire
- 1 year ago - Talis Biomedical Announces 1-for-15 Reverse Stock Split - GlobeNewsWire
- 1 year ago - TALIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Talis Biomedical Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - Business Wire
- 1 year ago - Talis Biomedical Appoints Former Roche Molecular CEO Heiner Dreismann to Board of Directors, Announces Former Genomic Health CEO Kim Popovits as Lead Independent Director - GlobeNewsWire